What's new
Evaluation, supervision and safety monitoring of medicines in the EU.
Publisher
EU
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Evaluation, supervision and safety monitoring of medicines in the EU.
Source route
Continue on ema.europa.eu
Leave the platform to read the original full article on the publisher site.
Source: European Medicines Agency (EMA)
Scope: Regulatory
Related coverage
More related coverage
WHO recommends new diagnostic tools to help end TB
On World TB Day, the World Health Organization (WHO) is urging countries to accelerate action to end...
Strengthening digital health capacities through blended learning
In many low- and middle-income countries, national digital health teams face a familiar reality: fra...
WHO calls for collective action to end tuberculosis
24 March 2026, Cairo, Egypt – Under the theme of this year’s World Tuberculosis Day (WTBD 2026) – Ye...
The EFPIA View
Past week (1) Past month (10) Past year (83) Older (1719) Past week (0) Past month (3) Past year (12...